This study from the Johns Hopkins Scleroderma Center found that scleroderma patients with multiple autoimmune responses may be protected from the development of cancer.
Multiple Autoimmune Responses in Scleroderma May Protect Against Cancer
About Erika Darrah
Dermatomyositis Autoantibodies associated with adverse skin reactions after treatment
Hydroxychloroquine sulfate is frequently used to treat patients with dermatomyositis. It has been associated with an increased risk of adverse skin reactions in these patients.
EnCOMPASSing the extent of “dysautonomia” in patients with Scleroderma
This study explores the prevalence and risk factors for “autonomic dysfunction” in scleroderma.
Maintenance therapy in well-controlled vasculitis: Is it ever ok to stop?
“Whether or not” and “how” to taper off the last bit of medication for patients with clinically stable ANCA-associated vasculitis are hotly debated topics in the vasculitis field.
Cancer immunotherapy regimens and clinical features of inflammatory arthritis
This is a study of 30 patients with immune checkpoint inhibitor induced inflammatory arthritis. Their clinical features and relationship to immunotherapy regimen were evaluated, as was the course of their arthritis.
Smoking is Not to Blame for PAD4 Antibody Development in Patients with RA
A new study from the Johns Hopkins Arthritis Center reveals that cigarette smoking is not linked to the development of antibodies to PAD4 in patients with severe rheumatoid arthritis.
